Chronic Neutrophilic Leukemia with V617F JAK2 Mutation

Area of Science:

• Hematology
• Oncology
• Molecular Diagnostics

Background:

• Chronic neutrophilic leukemia (CNL) is a rare World Health Organization-classified myeloproliferative neoplasm.
• CNL is a diagnosis of exclusion, characterized by sustained neutrophilia and splenomegaly without other identifiable causes.
• Distinguishing CNL from reactive neutrophilia can be diagnostically challenging.

Observation:

• This report details three cases of CNL.
• The V617F Janus kinase 2 (JAK 2) mutation was identified in all three CNL cases.
• The JAK 2 V617F mutation is typically associated with other classical myeloproliferative neoplasms.

Findings:

• The presence of the V617F JAK 2 mutation was confirmed in these CNL cases.
• This finding suggests a potential role for JAK 2 mutations in the pathogenesis of some CNL cases.
• The mutation's detection offers a valuable tool for confirming the neoplastic nature of neutrophilia.

Implications:

• Identifying the V617F JAK 2 mutation can serve as a diagnostic marker for CNL.
• This diagnostic capability helps differentiate neoplastic neutrophilia from reactive conditions.
• Further research into JAK 2 mutations in CNL may reveal targeted therapeutic strategies.